HIMS Stock Drops After Hours as Hims Launches $49 Wegovy-Style Pill and Novo Nordisk Pushes Back
Shares of Hims & Hers Health were hit by a sharp wave of selling after the company rolled out a lower-cost, compounded semaglutide pill positioned as a Wegovy alternative, triggering…







